Coherus Oncology, Inc. (CHRS)
1.41
-0.05
(-3.42%)
USD |
NASDAQ |
Aug 28, 16:00
1.40
-0.01
(-0.71%)
After-Hours: 20:00
Coherus Oncology Total Assets (Quarterly) : 191.18M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 191.18M |
| March 31, 2026 | 266.02M |
| December 31, 2025 | 265.77M |
| September 30, 2025 | 516.52M |
| June 30, 2025 | 439.46M |
| March 31, 2025 | 371.07M |
| December 31, 2024 | 454.85M |
| September 30, 2024 | 505.00M |
| June 30, 2024 | 674.86M |
| March 31, 2024 | 763.54M |
| December 31, 2023 | 629.60M |
| September 30, 2023 | 583.78M |
| June 30, 2023 | 469.59M |
| March 31, 2023 | 402.43M |
| December 31, 2022 | 480.85M |
| September 30, 2022 | 550.91M |
| June 30, 2022 | 546.00M |
| March 31, 2022 | 593.39M |
| December 31, 2021 | 679.33M |
| September 30, 2021 | 741.73M |
| June 30, 2021 | 739.54M |
| March 31, 2021 | 693.30M |
| December 31, 2020 | 841.65M |
| September 30, 2020 | 803.73M |
| June 30, 2020 | 756.61M |
| Date | Value |
|---|---|
| March 31, 2020 | 466.54M |
| December 31, 2019 | 408.93M |
| September 30, 2019 | 327.38M |
| June 30, 2019 | 240.46M |
| March 31, 2019 | 186.12M |
| December 31, 2018 | 99.47M |
| September 30, 2018 | 141.46M |
| June 30, 2018 | 188.31M |
| March 31, 2018 | 128.46M |
| December 31, 2017 | 162.61M |
| September 30, 2017 | 189.76M |
| June 30, 2017 | 172.25M |
| March 31, 2017 | 227.50M |
| December 31, 2016 | 178.48M |
| September 30, 2016 | 192.36M |
| June 30, 2016 | 251.10M |
| March 31, 2016 | 226.24M |
| December 31, 2015 | 212.38M |
| September 30, 2015 | 202.31M |
| June 30, 2015 | 249.55M |
| March 31, 2015 | 153.15M |
| December 31, 2014 | 187.22M |
| September 30, 2014 | 129.18M |
| June 30, 2014 | 122.18M |
| March 31, 2014 | 69.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | 296.87M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 130.34M |
| Shareholders Equity (Quarterly) | 60.84M |
| Debt to Equity Ratio | 0.8905 |
| Current Ratio | 1.772 |
| Net Debt Paydown Yield | 22.69% |